Financial instrument (Tables)
|
11 Months Ended |
12 Months Ended |
Mar. 31, 2025 |
Mar. 31, 2025 |
IfrsStatementLineItems [Line Items] |
|
|
Schedule of financial assets and liabilities |
The
following table analyses the financial assets and liabilities in the statement of financial position by the class of financial instruments
to which they are assigned, and therefore by the measurement basis:
Schedule
of financial assets and liabilities
| |
2025 | |
| |
USD | |
| |
| |
Financial assets | |
| | |
At amortised cost | |
| | |
Cash on hand | |
| 1 | |
| |
| | |
Financial liabilities | |
| | |
At amortised cost | |
| | |
Other payables and accrued expenses | |
| 18,503 | |
|
|
Alps Life Science Inc [Member] |
|
|
IfrsStatementLineItems [Line Items] |
|
|
Schedule of financial assets and liabilities |
|
The
following table analyses the financial assets and liabilities in the statement of financial position by the class of financial instruments
to which they are assigned, and therefore by the measurement basis:
Schedule of financial assets and liabilities
| |
2025 | | |
2024 | |
| |
USD | | |
USD | |
| |
| | |
| |
Financial assets | |
| | | |
| | |
At
amortised cost | |
| | | |
| | |
Trade receivables | |
| 45,528 | | |
| 74,016 | |
Other receivables and deposits | |
| 267,146 | | |
| 200,920 | |
Amount due from associates | |
| 18,435 | | |
| 2,145 | |
Cash and bank balances | |
| 318,932 | | |
| 460,467 | |
Financial assets at amortised cost | |
| 318,932 | | |
| 460,467 | |
| |
| | | |
| | |
Financial
assets | |
| 650,041 | | |
| 737,548 | |
29. |
Financial instrument (Cont’d) |
The
following table analyses the financial assets and liabilities in the statement of financial position by the class of financial instruments
to which they are assigned, and therefore by the measurement basis: (Cont’d)
| |
2025 | | |
2024 | |
| |
USD | | |
USD | |
| |
| | |
| |
Financial liabilities | |
| | | |
| | |
At
amortised cost | |
| | | |
| | |
Trade payables | |
| 321,350 | | |
| 175,599 | |
Other payables and accruals | |
| 864,910 | | |
| 849,451 | |
Amount due to associates | |
| 20,763 | | |
| - | |
Amount due to directors | |
| 5,972,257 | | |
| 3,610,711 | |
Hire purchase liabilities | |
| - | | |
| 7,260 | |
Lease
liabilities | |
| 961,875 | | |
| 500,308 | |
Financial liabilities at amortised cost
| |
| 961,875 | | |
| 500,308 | |
| |
| | | |
| | |
Financial
liabilities | |
| 8,141,155 | | |
| 5,143,329 | |
|
Schedule of maturity profile of the group’s financial liabilities |
|
The
table below summarises the maturity profile of the Group’s financial liabilities at the end of the reporting period based on undiscounted
contractual payments:
Schedule
of maturity profile of the group’s financial liabilities
| |
Interest
rate | | |
Total
carrying
amount | | |
On
demand or
within 1 year | | |
Within
2 to 5 years | | |
Total
undiscounted cash flow | |
| |
% | | |
USD | | |
USD | | |
USD | | |
USD | |
| |
| | |
| | |
| | |
| | |
| |
2025 | |
| | | |
| | | |
| | | |
| | | |
| | |
Non-interest bearing: | |
| | | |
| | | |
| | | |
| | | |
| | |
Trade payables | |
| - | | |
| 321,350 | | |
| 321,350 | | |
| - | | |
| 321,350 | |
Other payables and accruals | |
| - | | |
| 878,421 | | |
| 878,421 | | |
| - | | |
| 878,421 | |
Amount due to associates | |
| - | | |
| 20,763 | | |
| 20,763 | | |
| - | | |
| 20,763 | |
Amount due to directors | |
| - | | |
| 5,972,257 | | |
| 5,972,257 | | |
| - | | |
| 5,972,257 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Interest bearing: | |
| | | |
| | | |
| | | |
| | | |
| | |
Lease
liabilities | |
| 6.65 | | |
| 961,875 | | |
| 499,557 | | |
| 535,578 | | |
| 1,035,135 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| 8,154,666 | | |
| 7,692,348 | | |
| 535,578 | | |
| 8,227,926 | |
29. |
Financial instrument (Cont’d) |
| (ii) | Liquidity
risk (Cont’d) |
Analysis
of financial instruments by remaining contractual maturities (Cont’d)
The
table below summarises the maturity profile of the Group’s financial liabilities at the end of the reporting period based on undiscounted
contractual payments: (Cont’d)
| |
Interest
rate | | |
Total
carrying amount | | |
On
demand or
within 1 year | | |
Within
2 to 5 years | | |
Total
undiscounted cash flow | |
| |
% | | |
USD | | |
USD | | |
USD | | |
USD | |
| |
| | |
| | |
| | |
| | |
| |
2024 | |
| | | |
| | | |
| | | |
| | | |
| | |
Non-interest bearing: | |
| | | |
| | | |
| | | |
| | | |
| | |
Trade payables | |
| - | | |
| 175,599 | | |
| 175,599 | | |
| - | | |
| 175,599 | |
Other payables and accruals | |
| - | | |
| 956,063 | | |
| 956,063 | | |
| - | | |
| 956,063 | |
Amount due to directors | |
| - | | |
| 3,610,711 | | |
| 3,610,711 | | |
| - | | |
| 3,610,711 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Interest bearing: | |
| | | |
| | | |
| | | |
| | | |
| | |
Hire purchase liabilities | |
| 4.55 | | |
| 7,260 | | |
| 7,384 | | |
| - | | |
| 7,384 | |
Lease
liabilities | |
| 7.04 | | |
| 500,308 | | |
| 329,071 | | |
| 202,421 | | |
| 531,492 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| 5,249,941 | | |
| 5,078,828 | | |
| 202,421 | | |
| 5,281,249 | |
|
Schedule of financial assets and liabilities |
|
Summarised
financial information of Cilo Cybin is set out below. The summarised financial information represents the amount in the financial statements
of the associate and not the Group’s share of those amounts.
Schedule
of financial information represents the amount in the financial statements
| |
2025 | | |
2024 | |
| |
USD | | |
USD | |
Statement of financial position | |
| | | |
| | |
Non-current assets | |
| 198,858 | | |
| - | |
Current assets | |
| 3,139,920 | | |
| 3,354,690 | |
| |
| | | |
| | |
Total assets | |
| 3,338,778 | | |
| 3,354,690 | |
| |
| | | |
| | |
Non-current liabilities | |
| (173,968 | ) | |
| - | |
Current liabilities | |
| (114,958 | ) | |
| (593,538 | ) |
| |
| | | |
| | |
Total liabilities | |
| (288,926 | ) | |
| (593,538 | ) |
| |
| | | |
| | |
Net assets of the associate | |
| 3,049,852 | | |
| 2,761,152 | |
| |
| | | |
| | |
Statement of comprehensive
income | |
| | | |
| | |
Revenue for the financial
year | |
| 256,858 | | |
| 229,058 | |
| |
| | | |
| | |
(Loss)/Profit for the
financial year | |
| (31,156 | ) | |
| 21,809 | |
| |
| | | |
| | |
Share of (loss)/profit of the associate | |
| (12,618 | ) | |
| 8,833 | |
|